ESC Professional Premium Access

Great Debate: lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers

Event: ESC Congress 2022
Topic: Cardiovascular Pharmacotherapy
Session type: Great Debates
Date: 26 August 2022
Time: 11:15 - 12:15

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

3 presentations in this session

Lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers: pro.

Speaker: Professor S. Nicholls (Melbourne, AU)
Thumbnail

Lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers: con.

Speaker: Professor C. Baigent (Oxford, GB)
Thumbnail

Lipid-lowering therapies should be guided by vascular imaging rather than by plasma biomarkers – the final word.

Thumbnail

2 speakers from this session

Professor Stephen Nicholls

Monash Heart, Melbourne (Australia)
36 presentations
2 followers

Professor Colin Baigent

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
11 presentations
1 follower

This platform is supported by

logo Novo Nordisk